Author:
Barker David F.,Husain Anwar,Neale Jason R.,Martini Benjamin D.,Zhang Xiaoyan,Doll Mark A.,Christopher States J.,Hein David W.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics
Reference44 articles.
1. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms;Hein;Cancer Epidemol Biomarkers Prev,2000
2. Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening;Kawamura;Biochem Pharmacol,2005
3. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses;Garcia-Closas;Lancet,2005
4. NAT2 slow acetylation and bladder cancer in workers exposed to benzidine;Carreon;Int J Cancer,2006
5. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women;Deitz;Cancer Epidemiol Biomarkers Prev,2000
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献